Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Provenge extends prostate cancer survival by about 4 months.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Clinicians should be aware of alternating thyroid conditions and their treatment.

Intravenous and oral calcium effectively treated vitamin D dependent rickets type II, improving growth and bone health.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

A new compound was effective for imaging prostate cancer in rats.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Different forms of the Vitamin D receptor can impact metabolic and hormone issues in Polycystic Ovary Syndrome.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

DPCP can help regrow hair in some people with severe alopecia.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.